tiprankstipranks
Trending News
More News >
NFL Biosciences SA (DE:82F)
FRANKFURT:82F
Germany Market

NFL Biosciences SA (82F) Income Statement

Compare
1 Followers

NFL Biosciences SA Income Statement

Last quarter (Q2 2023), NFL Biosciences SA's total revenue was €0.00, a decrease of ― from previous quarter. In Q2, NFL Biosciences SA's net income was €-2.11M. See NFL Biosciences SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20
Total Revenue
€ 0.00€ 0.00€ 0.00
Gross Profit
€ -2.24M€ -530.73K€ -169.36K
Operating Expenses
€ 668.96K€ 588.77K€ 148.67K
Depreciation and Amortization
€ 52.44K€ 43.50K€ 41.96K
EBITDA
€ -2.81M€ -1.08M€ -271.09K
Operating Income
€ -3.08M€ -901.87K€ -318.03K
Other Income/Expenses
€ 221.86K€ -217.64K€ 4.98K
Pretax Income
€ -2.86M€ -1.12M€ -318.03K
Net Income
€ -2.44M€ -978.24K€ -266.49K
Per Share Metrics
Basic EPS
€ -0.47€ -0.19€ -0.05
Diluted EPS
€ -0.47€ -0.19€ -0.05
Weighted Average Shares Outstanding
5.23M 5.23M 5.23M
Weighted Average Shares Outstanding (Diluted)
5.23M 5.23M 5.23M
Currency in EUR

NFL Biosciences SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis